Tatva Chintan Pharma Chem (BOM:543321) ROCE %: 11.73% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:543321 Tatva Chintan Pharma Chem Ltd BOM:543321
79 GF Score
Price ₹1,428.45
GF Value ₹1,492.93
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Tatva Chintan Pharma Chem ROCE %?

Tatva Chintan Pharma Chem BOM:543321 +0.85% 79 ROCE % is 11.73% as of Jun. 2026. GuruFocus rates BOM:543321 with a GF Score™ of 79/100 and a GF Value™ of ₹1,492.93 (Fairly Valued). The stock has 6 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Tatva Chintan Pharma Chem's annualized ROCE % for the quarter that ended in Jun. 2026 was 11.73%.

Tatva Chintan Pharma Chem  (BOM:543321) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Tatva Chintan Pharma Chem ROCE % Related Terms

Tatva Chintan Pharma Chem ROCE % Historical Data

* Premium members only.

The historical data trend for Tatva Chintan Pharma Chem's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tatva Chintan Pharma Chem ROCE % Chart

Tatva Chintan Pharma Chem Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
ROCE %
Get a 7-Day Free Trial 31.73 10.48 7.90 1.20 7.82

Tatva Chintan Pharma Chem Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.14 7.50 9.61 9.12 11.73
BOM:543321
79GF Score
Tatva Chintan Pharma Chem Ltd BOM:543321
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tatva Chintan Pharma Chem ROCE % Calculation

Tatva Chintan Pharma Chem's annualized ROCE % for the fiscal year that ended in Mar. 2026 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=598.6/( ( (8362.49 - 960.27) + (10036.94 - 2131.35) )/ 2 )
=598.6/( (7402.22+7905.59)/ 2 )
=598.6/7653.905
=7.82 %

Tatva Chintan Pharma Chem's ROCE % of for the quarter that ended in Jun. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Jun. 2026 )  (Q: Mar. 2026 )(Q: Jun. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Jun. 2026 )  (Q: Mar. 2026 )(Q: Jun. 2026 )
=927.68/( ( (10036.94 - 2131.35) + (0 - 0) )/ 1 )
=927.68/( ( 7905.59 + 0 )/ 1 )
=927.68/7905.59
=11.73 %

(1) Note: The EBIT data used here is four times the quarterly (Jun. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 11.73% mean?
Tatva Chintan Pharma Chem (BOM:543321) has a ROCE % of 11.73% as of Jun. 2026.
Is Tatva Chintan Pharma Chem's ROCE % too high?
Tatva Chintan Pharma Chem's current ROCE % is 11.73%. The Chemicals industry median ROCE % is 6.52. Tatva Chintan Pharma Chem's value of 11.73% is 79.9% above this industry median. Overall, Tatva Chintan Pharma Chem has a GF Score™ of 79/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Tatva Chintan Pharma Chem's ROCE % compare to LIN and SHW?
Tatva Chintan Pharma Chem's ROCE % of 11.73% can be compared against companies in the Chemicals industry. The industry median ROCE % is 6.52. Tatva Chintan Pharma Chem's value of 11.73% is 79.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Chemicals company?
The median ROCE % among Chemicals companies is 6.52, based on 1,589 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Tatva Chintan Pharma Chem's current ROCE % of 11.73% is 79.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Chemicals industry, the median ROCE % is 6.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tatva Chintan Pharma Chem's current ROCE % is 11.73%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tatva Chintan Pharma Chem stock overvalued right now?
Based on GuruFocus' analysis, Tatva Chintan Pharma Chem (BOM:543321) is currently considered Fairly Valued. The stock's GF Value™ is ₹1,492.93, compared to a current price of ₹1,428.45 — trading 4.3% below its estimated fair value. The current ROCE % is 11.73% and 79.9% above the Chemicals industry median of 6.52. Tatva Chintan Pharma Chem's overall GF Score™ is 79/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Tatva Chintan Pharma Chem (BOM:543321), the current ROCE % is 11.73% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tatva Chintan Pharma Chem (BOM:543321) Overvalued in 2026?

Based on GuruFocus' analysis, Tatva Chintan Pharma Chem stock appears to be undervalued. The current stock price of ₹1,428.45 is trading 4.3% below its estimated GF Value™ of ₹1,492.93. GuruFocus considers Tatva Chintan Pharma Chem to be Fairly Valued.

Key valuation signals for BOM:543321:

  • ROCE %: 11.73%
  • GF Value™: ₹1,492.93 vs. price of ₹1,428.45 (4.3% below fair value)
  • GF Score™: 79/100 with 6 warning signs
  • Industry Position: 79.9% above the Chemicals median

No single metric tells the full story. See the BOM:543321 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Tatva Chintan Pharma Chem Business Description

Other Exchanges TATVA:India
Address Plot No. 353, Makarpura GIDC, Vadodara, GJ, IND, 390010
Tatva Chintan Pharma Chem Ltd is a specialty chemicals manufacturing company engaged in the manufacturing and selling of specialty chemicals, Pharma and Agro intermediates, Quaternary Compounds, and Quats. The company's product portfolio includes structure-directing agents, phase transfer catalysts, electrolyte salts for supercapacitor batteries, pharmaceutical and agrochemical intermediates and other specialty chemicals. The company sells its products in domestic as well as overseas markets, with the majority of revenue coming from overseas markets.
79GF Score

Get the complete analysis for BOM:543321

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,428.45
Price
₹1,492.93
GF Value